← The SEC Ephemeris: the whole map
Antares Pharma, Inc. hydrocortisone sodium phosphate
In the graph: all 2 documents (5 pages).
- Application
- NDA 218026
- Ticker
- Antares Pharma, Inc.
- Product
- hydrocortisone sodium phosphate
- Disease area
- Not yet classified
- Response path
- Not yet classified
- Complete Response Letters
- August 16, 2024 · October 20, 2017
From FDA letters and SEC filings. Not investment or medical advice.